AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 280: E59-E64, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Niwa, T.
Right arrow Articles by Niki, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niwa, T.
Right arrow Articles by Niki, I.
Vol. 280, Issue 1, E59-E64, January 2001

Lack of effect of incretin hormones on insulin release from pancreatic islets in the bile duct-ligated rats

Tae Niwa1,2, Yuji Nimura2, and Ichiro Niki1

1 Department of Cell Pharmacology and 2 Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

Hyperglycemia associated with obstructive jaundice seriously affects the prognosis of patients with hepatobiliary diseases. We investigated secretory properties of isolated islets from bile duct-ligated (BDL) rats. Pancreatic islets from BDL rats lost their secretory responses to glucagon-like peptide-1 (GLP-1), although their responses to glucose were normal. Loss of potentiation of insulin release was also observed in glucagon and glucose-dependent insulinotropic peptide (GIP), whereas modulation of the release by forskolin, dibutyryl cAMP, or epinephrine remained unaffected. cAMP production by BDL islets was not increased by these insulinotropic hormones. Serum levels of glucagon, but not GIP, were increased in BDL rats. GLP-1 levels were also elevated, although they did not reach statistical significance. Immunoblotting of trimeric G protein subunits demonstrated that Gsalpha L and Gsalpha S, but not Gialpha 1/2 and Gialpha 3/oalpha , were less expressed in BDL islets. Therefore, unresponsiveness of the beta -cell to cAMP-raising hormones is involved in glucose intolerance under cholestasis. It results from diminished expression of alpha -subunits of the relevant G protein, Gs, and desensitization of receptors of these hormones.

cholestasis; pancreatic beta -cell; glucagon-like peptide-1; trimeric G protein; adenosine 3',5'-cyclic monophosphate


This article has been cited by other articles:


Home page
GutHome page
M Marzioni, G Alpini, S Saccomanno, C Candelaresi, J Venter, C Rychlicki, G Fava, H Francis, L Trozzi, and A Benedetti
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
Gut, July 1, 2009; 58(7): 990 - 997.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online